Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
Reach out to your doctor if you notice any of the following: skin sensitivity that gets worse instead of better after two to three weeks, widespread rash or visible irritation that spreads beyond the injection area, blistering or peeling skin, or any signs of a serious allergic reaction like facial swelling, difficulty breathing, or a rapid heartbeat
Potential side effects include abdominal discomfort, constipation, diarrhea, nausea, vomiting, fatigue, headache
[PubMed] Gardner CD, Trepanowski JF, Del Gobbo LC, et al
On August 21, 2024, Gilead registered a Phase I clinical trial for its small-molecule GLP-1 receptor agonist GS-4571 for diabetes and obesity treatment on ClinicalTrials.gov
Blood pressure and heart rate monitoring provide adequate safeguards, particularly for sympathomimetic agents like phentermine that serve as viable alternatives for GLP-1 non-responders
Nithin Kamath In my understanding of GLP1s in India and Global, this doesnt fully capture the true on the ground picture
